These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 12730675)
1. Phenoxodiol--an isoflavone analog--induces apoptosis in chemoresistant ovarian cancer cells. Kamsteeg M; Rutherford T; Sapi E; Hanczaruk B; Shahabi S; Flick M; Brown D; Mor G Oncogene; 2003 May; 22(17):2611-20. PubMed ID: 12730675 [TBL] [Abstract][Full Text] [Related]
2. Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells. Lane D; Cartier A; L'Espérance S; Côté M; Rancourt C; Piché A Gynecol Oncol; 2004 Jun; 93(3):594-604. PubMed ID: 15196850 [TBL] [Abstract][Full Text] [Related]
3. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells. Sylvester PW; Shah S Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of CD95 apoptotic signaling by interferon-gamma in human osteoarthritic chondrocytes is associated with increased expression of FLICE inhibitory protein. Grassi F; Piacentini A; Cristino S; Toneguzzi S; Facchini A; Lisignoli G Arthritis Rheum; 2004 Feb; 50(2):498-506. PubMed ID: 14872492 [TBL] [Abstract][Full Text] [Related]
5. alpha-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells. Yu W; Shun MC; Anderson K; Chen H; Sanders BG; Kline K Apoptosis; 2006 Oct; 11(10):1813-23. PubMed ID: 16850165 [TBL] [Abstract][Full Text] [Related]
6. Up-regulation of FLIP in cisplatin-selected HeLa cells causes cross-resistance to CD95/Fas death signalling. Kamarajan P; Sun NK; Chao CC Biochem J; 2003 Nov; 376(Pt 1):253-60. PubMed ID: 12911332 [TBL] [Abstract][Full Text] [Related]
7. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma. Mezzanzanica D; Balladore E; Turatti F; Luison E; Alberti P; Bagnoli M; Figini M; Mazzoni A; Raspagliesi F; Oggionni M; Pilotti S; Canevari S Clin Cancer Res; 2004 Aug; 10(15):5202-14. PubMed ID: 15297424 [TBL] [Abstract][Full Text] [Related]
8. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line. Spierings DC; de Vries EG; Vellenga E; de Jong S Cell Death Differ; 2003 Jul; 10(7):808-22. PubMed ID: 12815464 [TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas. Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637 [TBL] [Abstract][Full Text] [Related]
10. FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation. Kataoka T; Schröter M; Hahne M; Schneider P; Irmler M; Thome M; Froelich CJ; Tschopp J J Immunol; 1998 Oct; 161(8):3936-42. PubMed ID: 9780161 [TBL] [Abstract][Full Text] [Related]
11. Resistance to TRAIL-induced apoptosis in ovarian cancer cell lines is overcome by co-treatment with cytotoxic drugs. Tomek S; Horak P; Pribill I; Haller G; Rössler M; Zielinski CC; Pils D; Krainer M Gynecol Oncol; 2004 Jul; 94(1):107-14. PubMed ID: 15262127 [TBL] [Abstract][Full Text] [Related]
12. Possible role of FLICE-like inhibitory protein (FLIP) in chemoresistant ovarian cancer cells in vitro. Abedini MR; Qiu Q; Yan X; Tsang BK Oncogene; 2004 Sep; 23(42):6997-7004. PubMed ID: 15258564 [TBL] [Abstract][Full Text] [Related]
13. X-linked inhibitor regulating TRAIL-induced apoptosis in chemoresistant human primary glioblastoma cells. Roa WH; Chen H; Fulton D; Gulavita S; Shaw A; Th'ng J; Farr-Jones M; Moore R; Petruk K Clin Invest Med; 2003 Oct; 26(5):231-42. PubMed ID: 14596484 [TBL] [Abstract][Full Text] [Related]
14. Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells. Mori T; Doi R; Kida A; Nagai K; Kami K; Ito D; Toyoda E; Kawaguchi Y; Uemoto S J Surg Res; 2007 Oct; 142(2):281-6. PubMed ID: 17640673 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis. Chawla-Sarkar M; Bae SI; Reu FJ; Jacobs BS; Lindner DJ; Borden EC Cell Death Differ; 2004 Aug; 11(8):915-23. PubMed ID: 15118763 [TBL] [Abstract][Full Text] [Related]
16. The antiproliferative effects of phenoxodiol are associated with inhibition of plasma membrane electron transport in tumour cell lines and primary immune cells. Herst PM; Petersen T; Jerram P; Baty J; Berridge MV Biochem Pharmacol; 2007 Dec; 74(11):1587-95. PubMed ID: 17904534 [TBL] [Abstract][Full Text] [Related]
17. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players. Hesry V; Piquet-Pellorce C; Travert M; Donaghy L; Jégou B; Patard JJ; Guillaudeux T Prostate; 2006 Jun; 66(9):987-95. PubMed ID: 16541419 [TBL] [Abstract][Full Text] [Related]
18. Subtoxic concentration of doxorubicin enhances TRAIL-induced apoptosis in human prostate cancer cell line LNCaP. Kang J; Bu J; Hao Y; Chen F Prostate Cancer Prostatic Dis; 2005; 8(3):274-9. PubMed ID: 15897917 [TBL] [Abstract][Full Text] [Related]
19. Rapid up-regulation of c-FLIP expression by BCR signaling through the PI3K/Akt pathway inhibits simultaneously induced Fas-mediated apoptosis in murine B lymphocytes. Moriyama H; Yonehara S Immunol Lett; 2007 Mar; 109(1):36-46. PubMed ID: 17275920 [TBL] [Abstract][Full Text] [Related]
20. Phenoxodiol, a novel approach for the treatment of ovarian cancer. Mor G; Fu HH; Alvero AB Curr Opin Investig Drugs; 2006 Jun; 7(6):542-8. PubMed ID: 16784025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]